Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3UA8

Crystal Structure Analysis of a 6-Amino Quinazolinedione Sulfonamide bound to human GluR2

Summary for 3UA8
Entry DOI10.2210/pdb3ua8/pdb
Related3R7X
DescriptorGlutamate receptor 2, N-methyl-1-{3-[(methylsulfonyl)amino]-2,4-dioxo-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinazolin-6-yl}-1H-imidazole-4-carboxamide (3 entities in total)
Functional Keywordsion channel, ionic channel, postsynaptic membrane, transmembrane, transport protein-antagonist complex, transport protein/antagonist
Biological sourceHomo sapiens (human)
More
Cellular locationCell membrane ; Multi-pass membrane protein : P42262
Total number of polymer chains1
Total formula weight29794.23
Authors
Kallen, J. (deposition date: 2011-10-21, release date: 2012-01-11, Last modification date: 2024-11-20)
Primary citationOrain, D.,Ofner, S.,Koller, M.,Carcache, D.A.,Froestl, W.,Allgeier, H.,Rasetti, V.,Nozulak, J.,Mattes, H.,Soldermann, N.,Floersheim, P.,Desrayaud, S.,Kallen, J.,Lingenhoehl, K.,Urwyler, S.
6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists.
Bioorg.Med.Chem.Lett., 22:996-999, 2012
Cited by
PubMed Abstract: A new set of quinazolinedione sulfonamide derivatives as competitive AMPA receptor antagonist with improved properties compared to 1 is disclosed. By modulating physico-chemical properties, compound 29 was identified with a low ED(50) of 5.5mg/kg in an animal model of anticonvulsant activity after oral dosage.
PubMed: 22197388
DOI: 10.1016/j.bmcl.2011.12.009
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon